RecruitingNCT07443826
CALM-AF-AI: Counteracting Age-related Loss of Muscle With AAV-Follistatin Combined With Angiogenesis-Inducing VEGF Plasmid Gene Therapy
PHASE1 · PHASE2 · 12 planned enrolment
- Countries listed
- 1
- Registry update
- July 13, 2026
immortal.lifeVerify the exact trial registrations behind a company, intervention, programme or topic count.
Showing 1–1 of 1. Every record below meets all the filters shown above.
PHASE1 · PHASE2 · 12 planned enrolment